NCT06912581

Brief Summary

A retrospective study conductet at Estonia's two regional hospitals. The data of patients hospitalised for SBO (small bowel obstruction) between 2015-2019 is retrospectively analysed. All other patients are excluded- except for previously unoperated ones (virgin abdomen). Study group analyses whether patients were operated on or was conservative management initiated. It will be studied, if any further medical studies have been done within 2 years of hospitalisation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
Last Updated

April 4, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

March 24, 2025

Last Update Submit

March 31, 2025

Conditions

Keywords

virgin abdomen SBO

Outcome Measures

Primary Outcomes (1)

  • SBO resolution at admission

    Patients who have been admitted. The primary outcome measure is SBO resolution within hospitalisation. Usually the conservative treatment is safe and feasible if no alarming symptoms (suggesting bowel ischaemia) are present (but can be prolonged op to 120 hours). Guidelines suggest conservative management up to 72 hours, but no clear guideline is present. The resolution will be assessed clinically- return of bowel movement and passing of gas or radiologically- CM in the large bowel in the follow-through.

    within hospitalisation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalised for SBO

You may qualify if:

  • Patients diagnosed with SBO Have not been operated previously

You may not qualify if:

  • Age less than 18 years History of previous operatsions Large bowel obstruction Dynamic ileus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tartu univeristy clinic

Tartu, Tartu, 51008, Estonia

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General surgeon, PhD student

Study Record Dates

First Submitted

March 24, 2025

First Posted

April 4, 2025

Study Start

May 30, 2023

Primary Completion

September 30, 2023

Study Completion

December 21, 2023

Last Updated

April 4, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.

Locations